Fibromyalgia is a disorder characterized by widespread sensory pain with fatigue, sleep, memory, and mood problems. Other symptoms include a degree of fatigue that affects normal activities, sleep problems, and memory problems. These symptoms are often accompanied by restless sleep, chronic fatigue, anxiety, depression, and bowel disorders. This disorder is often misdiagnosed or unknown and is often complicated by mood and anxiety disorders. Fibromyalgia is often associated with frequent depression, anxiety, and posttraumatic stress disorder other types of chronic pain.
Symptoms begin even after physical trauma, surgery, infection, or significant stress. Environmental factors can include stress, trauma, and certain infections. Pain occurs as a result of central nervous system processes and is referred to as “central sensitivity syndrome.” However, there is no specific diagnostic test for fibromyalgia, which can be a challenge for physicians when diagnosing the disease. Also, the symptoms of fibromyalgia can be similar to other conditions, which can lead to a misdiagnosis. There is no specific diagnostic test. Diagnosis involves first denying other possible causes and verifying that a set number of symptoms are present.
According to the criteria of the American College of Rheumatology Diagnosis, fibromyalgia affects about 3-5% of women, most of whom are between 20 and 50 years of age, but only 0.5-1.6% of men. Some experts think the actual rate is much higher. Fibromyalgia can be difficult to treat. Recommendations often include adequate sleep, regular exercise, and a healthy diet. In the nineteenth century, Florence Nightingale, an English army nurse, and Red Cross pioneer fell ill while working on the front lines during the Crimean War (1854 – 1866). He never fully recovered and suffered from relentless pain and depression until his death in 1910 and was bedridden most of the time. Prices remain the same in different regions of the world and in different cultures. The definition of fibromyalgia was last defined in 1990 with updated criteria in 2011. Pain is the main symptom of fibromyalgia, with stiffness, tenderness, and stiffness of multiple muscles, joints, and soft tissues. Pain also tends to move from one part of the body to another. The US Food and Drug Administration (FDA) then approved Lyrica, the first drug approved for the treatment of fibromyalgia. Although Lyrica can only improve symptoms for about 30-40% of fibromyalgia patients, its approval made a very large difference for all FM patients for a number of reasons.
Symptoms of fatigue are accompanied by anxiety about a person’s chronic pain and problems. Thus, some individuals may have increased susceptibility to fibromyalgia due to a predisposition to genetic factors. Fibromyalgia seems to be associated with increased sensitivity and activation of pain receptors. Since the pain response is broadened in patients with fibromyalgia, what they see as painful stimuli usually seems painless in healthy individuals. People who take responsibility for their pain and try to work often have milder symptoms and improved quality of life than people who focus on disability and discomfort.
